Literature DB >> 27625431

Cytokines and T-Cell Homeostasis in HIV Infection.

Michael L Freeman1, Carey L Shive2, Thao P Nguyen1, Souheil-Antoine Younes1, Soumya Panigrahi1, Michael M Lederman1.   

Abstract

Untreated human immunodeficiency virus (HIV) infection is characterized by progressive CD4(+) T-cell depletion and CD8(+) T-cell expansion, and CD4(+) T-cell depletion is linked directly to the risk for opportunistic infections and infection-associated mortality. With suppression of HIV replication by antiretroviral therapy, circulating CD4(+) Tcell numbers typically improve while CD8(+) T-cell expansion persists, and both CD4(+) T-cell cytopenia and CD8(+) T-cell expansion are associated with morbidity and mortality. In this brief review, we report on the role that selected homeostatic and inflammatory cytokines may play both in the failure of CD4(+) T-cell restoration and the CD8(+) T-cell expansion that characterize HIV infection.
© The Author 2016. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail journals.permissions@oup.com.

Entities:  

Keywords:  HIV; T cells; cytokines

Mesh:

Substances:

Year:  2016        PMID: 27625431      PMCID: PMC6373575          DOI: 10.1093/infdis/jiw287

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  50 in total

Review 1.  T cell dynamics in HIV-1 infection.

Authors:  Daniel C Douek; Louis J Picker; Richard A Koup
Journal:  Annu Rev Immunol       Date:  2001-12-19       Impact factor: 28.527

2.  IL-6 increases primed cell expansion and survival.

Authors:  Irina Rochman; William E Paul; S Z Ben-Sasson
Journal:  J Immunol       Date:  2005-04-15       Impact factor: 5.422

3.  Lymphatic tissue fibrosis is associated with reduced numbers of naive CD4+ T cells in human immunodeficiency virus type 1 infection.

Authors:  Timothy W Schacker; Jason M Brenchley; Gregory J Beilman; Cavan Reilly; Stefan E Pambuccian; Jodie Taylor; David Skarda; Matthew Larson; Daniel C Douek; Ashley T Haase
Journal:  Clin Vaccine Immunol       Date:  2006-05

4.  Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in crohn disease and experimental colitis in vivo.

Authors:  R Atreya; J Mudter; S Finotto; J Müllberg; T Jostock; S Wirtz; M Schütz; B Bartsch; M Holtmann; C Becker; D Strand; J Czaja; J F Schlaak; H A Lehr; F Autschbach; G Schürmann; N Nishimoto; K Yoshizaki; H Ito; T Kishimoto; P R Galle; S Rose-John; M F Neurath
Journal:  Nat Med       Date:  2000-05       Impact factor: 53.440

5.  Involvement of Bcl-2 and IL-2R in HIV-positive patients whose CD4 cell counts fail to increase rapidly with highly active antiretroviral therapy.

Authors:  Denis David; Hélène Keller; Lella Naït-Ighil; Marie-Pierre Treilhou; Marcel Joussemet; Bertrand Dupont; Bertrand Gachot; Jean Maral; Jacques Thèze
Journal:  AIDS       Date:  2002-05-24       Impact factor: 4.177

6.  Interleukin-6 regulation of transforming growth factor (TGF)-beta receptor compartmentalization and turnover enhances TGF-beta1 signaling.

Authors:  Xiao Liang Zhang; Nicholas Topley; Takafumi Ito; Aled Phillips
Journal:  J Biol Chem       Date:  2005-01-20       Impact factor: 5.157

Review 7.  The soluble interleukin 6 receptor: mechanisms of production and implications in disease.

Authors:  S A Jones; S Horiuchi; N Topley; N Yamamoto; G M Fuller
Journal:  FASEB J       Date:  2001-01       Impact factor: 5.191

8.  Cardiomyocyte-restricted knockout of STAT3 results in higher sensitivity to inflammation, cardiac fibrosis, and heart failure with advanced age.

Authors:  Jörg J Jacoby; April Kalinowski; Mu-Gen Liu; Samuel S-M Zhang; Qian Gao; Gui-Xuan Chai; Lan Ji; Yoshiki Iwamoto; En Li; Michael Schneider; Kerry S Russell; Xin-Yuan Fu
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-17       Impact factor: 11.205

9.  Essential involvement of IL-6 in the skin wound-healing process as evidenced by delayed wound healing in IL-6-deficient mice.

Authors:  Zi-Qing Lin; Toshikazu Kondo; Yuko Ishida; Tatsunori Takayasu; Naofumi Mukaida
Journal:  J Leukoc Biol       Date:  2003-06       Impact factor: 4.962

10.  Inhibition of T cell apoptosis in the aqueous humor of patients with uveitis by IL-6/soluble IL-6 receptor trans-signaling.

Authors:  S John Curnow; Dagmar Scheel-Toellner; Will Jenkinson; Karim Raza; Omar M Durrani; Jeff M Faint; Saaeha Rauz; Kaska Wloka; Darrell Pilling; Stefan Rose-John; Christopher D Buckley; Philip I Murray; Mike Salmon
Journal:  J Immunol       Date:  2004-10-15       Impact factor: 5.422

View more
  29 in total

Review 1.  The role of IL-6 in host defence against infections: immunobiology and clinical implications.

Authors:  Stefan Rose-John; Kevin Winthrop; Leonard Calabrese
Journal:  Nat Rev Rheumatol       Date:  2017-06-15       Impact factor: 20.543

Review 2.  The Role of the BCL-2 Family of Proteins in HIV-1 Pathogenesis and Persistence.

Authors:  Aswath P Chandrasekar; Nathan W Cummins; Andrew D Badley
Journal:  Clin Microbiol Rev       Date:  2019-10-30       Impact factor: 26.132

3.  PLA2G1B is involved in CD4 anergy and CD4 lymphopenia in HIV-infected patients.

Authors:  Julien Pothlichet; Thierry Rose; Florence Bugault; Louise Jeammet; Annalisa Meola; Ahmed Haouz; Frederick Saul; David Geny; José Alcami; Ezequiel Ruiz-Mateos; Luc Teyton; Gérard Lambeau; Jacques Thèze
Journal:  J Clin Invest       Date:  2020-06-01       Impact factor: 14.808

Review 4.  Inflammation, Immune Senescence, and Dysregulated Immune Regulation in the Elderly.

Authors:  Carey Shive; Pushpa Pandiyan
Journal:  Front Aging       Date:  2022-04-27

5.  Upregulation of IL-32 Isoforms in Virologically Suppressed HIV-Infected Individuals: Potential Role in Persistent Inflammation and Transcription From Stable HIV-1 Reservoirs.

Authors:  Sarah M Zaidan; Louise Leyre; Rémi Bunet; Etienne Larouche-Anctil; Isabelle Turcotte; Mohamed Sylla; Annie Chamberland; Carl Chartrand-Lefebvre; Petronela Ancuta; Jean-Pierre Routy; Jean-Guy Baril; Benoit Trottier; Paul MacPherson; Sylvie Trottier; Marianne Harris; Sharon Walmsley; Brian Conway; Alexander Wong; Réjean Thomas; Robert C Kaplan; Alan L Landay; Madeleine Durand; Nicolas Chomont; Cécile L Tremblay; Mohamed El-Far
Journal:  J Acquir Immune Defic Syndr       Date:  2019-12-15       Impact factor: 3.731

6.  Chronic HIV infection induces transcriptional and functional reprogramming of innate immune cells.

Authors:  Wouter A van der Heijden; Lisa Van de Wijer; Farid Keramati; Wim Trypsteen; Sofie Rutsaert; Rob Ter Horst; Martin Jaeger; Hans Jpm Koenen; Hendrik G Stunnenberg; Irma Joosten; Paul E Verweij; Jan van Lunzen; Charles A Dinarello; Leo Ab Joosten; Linos Vandekerckhove; Mihai G Netea; André Jam van der Ven; Quirijn de Mast
Journal:  JCI Insight       Date:  2021-04-08

Review 7.  Dysfunctional Immunometabolism in HIV Infection: Contributing Factors and Implications for Age-Related Comorbid Diseases.

Authors:  Tiffany R Butterfield; Alan L Landay; Joshua J Anzinger
Journal:  Curr HIV/AIDS Rep       Date:  2020-04       Impact factor: 5.071

Review 8.  Are BET Inhibitors yet Promising Latency-Reversing Agents for HIV-1 Reactivation in AIDS Therapy?

Authors:  Thanarat Salahong; Christian Schwartz; Rungroch Sungthong
Journal:  Viruses       Date:  2021-05-29       Impact factor: 5.048

9.  Anti-HIV Activity of Cucurbitacin-D against Cigarette Smoke Condensate-Induced HIV Replication in the U1 Macrophages.

Authors:  Sunitha Kodidela; Namita Sinha; Asit Kumar; Santosh Kumar
Journal:  Viruses       Date:  2021-05-27       Impact factor: 5.048

10.  Provirus reactivation is impaired in HIV-1 infected individuals on treatment with dasatinib and antiretroviral therapy.

Authors:  Lorena Vigón; Paula Martínez-Román; Sara Rodríguez-Mora; Montserrat Torres; María C Puertas; Elena Mateos; María Salgado; Antonio Navarro; Matilde Sánchez-Conde; Juan Ambrosioni; Miguel Cervero; Christoph Wyen; Christian Hoffmann; José M Miró; José Alcamí; Daniel Podzamczer; Valentín García-Gutiérrez; Javier Martínez-Picado; Verónica Briz; María Rosa López-Huertas; Vicente Planelles; Mayte Coiras
Journal:  Biochem Pharmacol       Date:  2021-06-26       Impact factor: 6.100

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.